TipRanks
Advertisement
Advertisement
Oppenheimer says VK2735’s options create compelling reason to own Viking
PremiumThe FlyOppenheimer says VK2735’s options create compelling reason to own Viking
1M ago
Viking Therapeutics: Why This Clinical-Stage, Licensed-Technology Play Is a Highly Speculative Bet for Equity Investors
Premium
Company Announcements
Viking Therapeutics: Why This Clinical-Stage, Licensed-Technology Play Is a Highly Speculative Bet for Equity Investors
2M ago
Viking Therapeutics Earnings Call Signals Obesity Push
Premium
Company Announcements
Viking Therapeutics Earnings Call Signals Obesity Push
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100